Evaluation
RequiredRequired Question(s)
1.
How well did the program meet the following educational objectives?
 Not achieved Partially achieved Average Very well Excellent 
Recognize why substance use disorder treatment is a primary care issue.
Discuss how to appropriately order and interpret urine toxicology to monitor patient adherence to treatment.
Explore prevention practices to reduce the risk of child maltreatment in families with substance abuse history.
Describe the role of the pharmacist in opioid harm reduction, including naloxone provision.
Learn how the NAS numbers in Kentucky reflect our state response to the opioid crisis.
State the three area of priority in the Kentucky Opioid Response Effort (KORE) and be able to describe one program in area of focus.
Please evaluate the effectiveness of each presenter: 
 
2.
Addiction Medicine is Primary Care Medicine: Integrating Buprenorphine
Treatment into Your Primary Care Practice
Melissa Zook, MD, FAAFP, AAHIVS


 Not Achieved Partially achieved Average Very well Excellent 
Knowledge
Delivery
Organization
Teaching Methods
3.

Do you think this lecture will impact your practice/work setting?
If so, what changes will you make?


 

50 characters left.
4.
The Balancing Act: Mitigating Risk When Prescribing Controlled Substances
Melissa Zook, MD, FAAFP, AAHIVS



 Not Achieved Partially achieved Average Very well Excellent 
Knowledge
Delivery
Organization
Teaching Methods
5.

Do you think this lecture will impact your practice/work setting?
If so, what changes will you make?

 

50 characters left.
6.


The Correlation between Substance Abuse and Child Maltreatment
Janna Estep-Jordan
 Not Achieved Partially achieved Average Very well Excellent 
Knowledge
Delivery
Organization
Teaching Methods
7.

Do you think this lecture will impact your practice/work setting?
If so, what changes will you make?

 

50 characters left.
8.
Engaging Pharmacists as Partners in Opioid Harm Reduction
Patricia R. Freeman, RPh, PhD



 Not Achieved Partially achieved Average Very well Excellent 
Knowledge
Delivery
Organization
Teaching Methods
9.

Do you think this lecture will impact your practice/work setting?
If so, what changes will you make?

 

50 characters left.
10.
Neonatal Abstinence Syndrome in Kentucky What does our data mean?
Henrietta S. Bada, MD



 Not Achieved Partially achieved Average Very well Excellent 
Knowledge
Delivery
Organization
Teaching Methods
11.

Do you think this lecture will impact your practice/work setting?
If so, what changes will you make?

 

50 characters left.
12.
Overview of the Kentucky Opioid Response Effort (KORE):  An Update on the Crisis and
Kentucky's Strategies to Stem the Tide
Allen J. Brenzel, MD, MBA


 Not Achieved Partially achieved Average Very well Excellent 
Knowledge
Delivery
Organization
Teaching Methods
13.

Do you think this lecture will impact your practice/work setting?
If so, what changes will you make?
 

 

50 characters left.
Required 14.

 

 
Which of the following barriers do you experience that have an impact on patient outcomes? 


Patient compliance issues
Cost
Reimbursement/ insurance issues
Lack of opportunity (patients)
Lack of resources (equipment)
Lack of time to assess/counsel patients
Lack of consensus or professional guidelines
Lack if administrative support
Lack of experience
Lack of transportation
Patient compliance
No insurance
Health literacy
Other  
  • Comment:

  • 500 characters left.
15.

Were you aware of the speaker's disclosure before the conference? 

(Disclosures are printed on the back of the agenda) 



Yes
No
16.

Please rate the overall program:

 Excellent Very Good Good Fair Poor 
The content was relevant to the announced topic
My personal objectives were achieved
The sophistication of the content was appropriate for me
17.

Suggested topics/speakers for next years conference. 


 

50 characters left.
18.

Was this program free from commercial bias?

Yes
No
19.

In no, please explain:

 

50 characters left.
20.
Other questions specific to program or provider:
 

50 characters left.